These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26700604)

  • 1. A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs.
    Ueda H; Muranushi N; Sakuma S; Ida Y; Endoh T; Kadota K; Tozuka Y
    Pharm Res; 2016 Apr; 33(4):1018-29. PubMed ID: 26700604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-amorphous Formation Induced by Combination of Tranilast and Diphenhydramine Hydrochloride.
    Ueda H; Kadota K; Imono M; Ito T; Kunita A; Tozuka Y
    J Pharm Sci; 2017 Jan; 106(1):123-128. PubMed ID: 27539557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
    Kasten G; Lobo L; Dengale S; Grohganz H; Rades T; Löbmann K
    Eur J Pharm Biopharm; 2018 Nov; 132():192-199. PubMed ID: 30266670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
    Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
    Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
    Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
    Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen.
    Ueda H; Wakabayashi S; Kikuchi J; Ida Y; Kadota K; Tozuka Y
    Mol Pharm; 2015 Apr; 12(4):1050-61. PubMed ID: 25654583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
    Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
    J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
    Beyer A; Radi L; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Jul; 104():72-81. PubMed ID: 27130786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of co-amorphous systems from naproxen and naproxen sodium and in situ monitoring of physicochemical state changes during dissolution testing by Raman spectroscopy.
    Ueda H; Peter Bøtker J; Edinger M; Löbmann K; Grohganz H; Müllertz A; Rades T; Østergaard J
    Int J Pharm; 2020 Sep; 587():119662. PubMed ID: 32682958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
    Paudel A; Loyson Y; Van den Mooter G
    J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of in situ granulation and temperature quenching on crystal habit and micromeritic properties of ibuprofen-cationic dextran conjugate crystanules.
    Abioye AO; Kola-Mustapha A; Ruparelia K
    Int J Pharm; 2014 Feb; 462(1-2):83-102. PubMed ID: 24378327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the molecular mobility and flexibility of the saccharide ring affect the glass-forming ability of naproxen in binary mixtures?
    Minecka A; Kamińska E; Tarnacka M; Jurkiewicz K; Talik A; Wolnica K; Dulski M; Kasprzycka A; Spychalska P; Garbacz G; Kamiński K; Paluch M
    Eur J Pharm Sci; 2020 Jan; 141():105091. PubMed ID: 31655208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the physicochemical properties of Co-amorphous naproxen-indomethacin by naproxen-sodium.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Int J Pharm; 2017 Jun; 526(1-2):88-94. PubMed ID: 28392278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Intermolecular Interactions, Dimeric Structures on the Glass Forming Ability of Naproxen, and a Series of Its Derivatives.
    Minecka A; Kaminska E; Tarnacka M; Grudzka-Flak I; Bartoszek M; Wolnica K; Dulski M; Kaminski K; Paluch M
    Mol Pharm; 2018 Oct; 15(10):4764-4776. PubMed ID: 30156420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy.
    Kilpeläinen T; Ervasti T; Uurasjärvi E; Koistinen A; Ketolainen J; Korhonen O; Pajula K
    Eur J Pharm Biopharm; 2022 Nov; 180():161-169. PubMed ID: 36122786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.